Market Overview The direct to consumer DTC genetic testing market is transforming as pharmacogenomics revolutionizes medication selection with genetic-guided prescribing. The Direct To Consumer DTC Genetic Testing Market is projected to reach $7.2 billion by 2035, growing at 15.7% CAGR, driven by adverse drug reaction concern, precision medicine adoption, and demand for effective first-line...